146
Participants
Start Date
August 13, 2013
Primary Completion Date
July 2, 2018
Study Completion Date
December 21, 2018
Peanut Oral Immunotherapy - Liquid Extract
Used during initial dose escalation for doses 0.1 to 0.8 mg.
Placebo for Peanut Oral Immunotherapy - Liquid Extract form
Similar in appearance, texture, and taste to peanut liquid extract.
Peanut Oral Immunotherapy - Peanut Flour
This will be used for the remainder of dose escalation, build-up, and maintenance.
Placebo for Peanut Oral Immunotherapy - Peanut Flour
Similar in appearance, texture, and taste to peanut flour.
Mount Sinai School of Medicine, New York
Johns Hopkins Hospital, Baltimore
UNC Chapel-Hill, Chapel Hill
University of Arkansas for Medical Sciences: Arkansas Children's Hospital, Little Rock
Stanford University School of Medicine, Stanford
Immune Tolerance Network (ITN)
NETWORK
National Institute of Allergy and Infectious Diseases (NIAID)
NIH